VP Business Development | VC-Backed Biotech

VP, Business Development | VC-Backed Biotech | Remote, USA** Remote, USA (Travel as needed) Competitive base + bonus + equity Biotechnology | Business DevelopmentJob ** Full-time | PermanentJob DescriptionA high-growth VC-backed biotech in the Oncology space is seeking a VP of Business Development to lead strategic partnerships, licensing, and corporate development. This is an exciting opportunity to drive deal-making, alliances, and investment strategy within a biotech at a critical stage of growth.Key ResponsibilitiesDevelop and execute the business development strategy, identifying and securing high-value partnerships.Lead in-licensing and out-licensing discussions for assets in preclinical and clinical stages.Negotiate and close collaborations, joint ventures, and strategic alliances with biopharma partners.Work closely with the executive team on fundraising, M&A, and corporate strategy.Build and maintain strong relationships with biopharma, investors, and VC partners.Candidate Profile10+ years in biotech BD, corporate development, or investment.Proven track record of closing deals, partnerships, and licensing agreements.Expertise in Oncology, Neurology, or Immunology with a strong understanding of drug development.Strong network with biopharma, biotech investors, and VC firms.Experience in a VC-backed or emerging biotech is highly desirable.Why Apply?✅ Strategic Leadership - Drive BD, licensing, and corporate partnerships in a high-growth biotech.✅ Competitive Package - Base salary + performance-based bonus + equity.✅ Remote Flexibility - Work from anywhere in the U.S., with travel as required.Desired Skills and Experience10+ years in biotech BD, corporate development, or investment.Proven track record of closing deals, partnerships, and licensing agreements.Expertise in Oncology, Neurology, or Immunology with a strong understanding of drug development.Strong network with biopharma, biotech investors, and VC firms.Experience in a VC-backed or emerging biotech is highly desirable.

Created: 2025-02-22